Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Depreciation and Depletion (2016 - 2019)

Historic Depreciation and Depletion for Amicus Therapeutics (FOLD) over the last 6 years, with Q1 2019 value amounting to $991000.0.

  • Amicus Therapeutics' Depreciation and Depletion rose 227.04% to $991000.0 in Q1 2019 from the same period last year, while for Mar 2019 it was $4.2 million, marking a year-over-year increase of 1270.69%. This contributed to the annual value of $5.0 million for FY2024, which is 416.67% up from last year.
  • Amicus Therapeutics' Depreciation and Depletion amounted to $991000.0 in Q1 2019, which was up 227.04% from $1.2 million recorded in Q4 2018.
  • Amicus Therapeutics' Depreciation and Depletion's 5-year high stood at $1.2 million during Q4 2018, with a 5-year trough of $353000.0 in Q2 2015.
  • Moreover, its 5-year median value for Depreciation and Depletion was $873500.0 (2016), whereas its average is $830562.5.
  • Per our database at Business Quant, Amicus Therapeutics' Depreciation and Depletion crashed by 1085.86% in 2015 and then surged by 12683.54% in 2016.
  • Amicus Therapeutics' Depreciation and Depletion (Quarter) stood at $395000.0 in 2015, then surged by 129.37% to $906000.0 in 2016, then increased by 22.96% to $1.1 million in 2017, then rose by 6.37% to $1.2 million in 2018, then dropped by 16.37% to $991000.0 in 2019.
  • Its Depreciation and Depletion was $991000.0 in Q1 2019, compared to $1.2 million in Q4 2018 and $1.1 million in Q3 2018.